Journal of the Pancreas | Citations & Metrics Report

Articles published in Journal of the Pancreas have been cited by esteemed scholars and scientists all around the world. Journal of the Pancreas has got h-index 80, which means every article in Journal of the Pancreas has got 80 average citations.

Following are the list of articles that have cited the articles published in Journal of the Pancreas.

	2021	2020	2019	2018	2017
Year wise published articles	53	36	35	69	96
Year wise citations received	1993	1923	1995	2086	2369

Journal total citations count	39440
Journal impact factor	19.45*
Journal 5 years impact factor
Journal cite score	29.12
Journal h-index	80

Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescore_y = Citations_y + Citations_y-1 + Citations_y-2 + Citations _y-3 / Published articles_y + Published articles_y-1 + Published articles_y-2 + Published articles _y-3

Important citations

Guerra F, Barucca V, Coletta D. Metastases or primary recurrence to the lung is related to improved survival of pancreatic cancer as compared to other sites of dissemination. Results of a systematic review with meta-analysis. Eur J Surg Oncol 2020; 46:1789-1794. [PMID: 32753117] View at Publisher View at Google Scholar View at Indexing
Sahni S, Moon EA, Howell VM, Mehta S, Pavlakis N, Chan D, et al. Tissue biomarker panel as a surrogate marker for squamous subtype of pancreatic cancer. Eur J Surg Oncol 2020; 46:1539-1542. [PMID: 32061458]. View at Publisher View at Google Scholar View at Indexing
Hyde AJ, Nassabein R, AlShareef A, Armstrong D, Babak S, Berry S, et al. Eastern Canadian gastrointestinal cancer consensus conference 2018. Current Oncology 2019; 26:665-681. [PMID: 31708660]. View at Publisher View at Google Scholar View at Indexing
Suzuki F, Fujiwara Y, Hamura R, Haruki K, Sakamoto T, Shiba H, et al. Combination of distance from superior mesenteric artery and serum CA19-9 as a novel prediction of local recurrence in patients with pancreatic cancer following resection. Anticancer Res 2019; 39:1469-78. View at Publisher View at Google Scholar View at Indexing
Furukawa K, Shiba H, Hamura R, Haruki K, Fujiwara Y, Usuba T, et al. Prognostic factors in patients with recurrent pancreatic cancer: A multicenter database analysis. Anticancer Res 2020; 40:293-298. [PMID: 31892579]. View at Publisher View at Google Scholar View at Indexing
Tanaka M, Mihaljevic AL, Probst P, Heckler M, Klaiber U, Heger U, et al. Meta-analysis of recurrence pattern after resection for pancreatic cancer. Journal of British Surgery 2019; 106:1590-601. [PMID: 31454073]. View at Publisher View at Google Scholar View at Indexing
Xelwa N, Candy GP, Devar J, Omoshoro-Jones J, Smith M, Nweke EE. Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance. Front Oncol. 2021; 11: 683788. [PMID: 34195085]. View at Publisher View at Google Scholar View at Indexing
Frequency of Raised Serum CRP in Acute Pancreatitis- A CrossSectional Study at Lahore General Hospital. PJMHS 2018; 12:999-1001. View at Publisher View at Google Scholar View at Indexing
Kim DU, Bae GS, Kim MJ, Choi JW, Kim DG, Song HJ, Park SJ. Icariin attenuates the severity of cerulein?induced acute pancreatitis by inhibiting p38 activation in mice. Int J Mol Med 2019; 44:1563-73. [PMID: 31432106]. View at Publisher View at Google Scholar View at Indexing
Dima A, Balaban DV, Jurcut C, Jinga M. Systemic lupus erythematosus-related acute pancreatitis. Lupus 2021; 30:5-14. [PMID: 33307986]. View at Publisher View at Google Scholar View at Indexing
Chue BM, La Course BD. Can we cure stage IV triple-negative breast carcinoma? Another case report of long-term survival (7 years). Medicine (Baltimore) 2019; 98:e17251. [PMID: 31567994]. View at Publisher View at Google Scholar View at Indexing
Chue BM, La Course BD. Case report of long-term survival with metastatic triple-negative breast carcinoma- Treatment possibilities for metastatic disease. Medicine (Baltimore). 2019; 98:e15302. [PMID: 31008982]. View at Publisher View at Google Scholar View at Indexing
de Vries C, Konukiewitz B, Weichert W, Klöppel G, Aupperle-Lellbach H, Steiger K. Do Canine Pancreatic Neuroendocrine Neoplasms Resemble Human Pancreatic Neuroendocrine Tumours? A Comparative Morphological and Immunohistochemical Investigation. J Comp Pathol 2020; 181:73-85. [PMID: 33288156]. View at Publisher View at Google Scholar View at Indexing
Segaran N, Devine C, Wang M, Ganeshan D. Current update on imaging for pancreatic neuroendocrine neoplasms. World J Clin Oncol 2021; 12:897-911. [PMID: 34733612]. View at Publisher View at Google Scholar View at Indexing
Khanna L, Prasad SR, Sunnapwar A, Kondapaneni S, Dasyam A, Tammisetti VS, et al. Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification. Radiographics 2020; 40:1240-1262. [PMID: 32795239]. View at Publisher View at Google Scholar View at Indexing
Oka N, Kasajima A, Konukiewitz B, Sakurada A, Okada Y, Kameya T. Classification and Prognostic Stratification of Bronchopulmonary Neuroendocrine Neoplasms. Neuroendocrinology 2020; 110:393-403. [PMID: 31422400]. View at Publisher View at Google Scholar View at Indexing
The Molecular and Clinical Landscape of Pancreatic Neuroendocrine Tumors. Pancreas 2019; 48:9-21. [PMID: 30531241]. View at Publisher View at Google Scholar View at Indexing
Wan Y, Hao H, Meng S, Li Z, Yu F, Chi M, et al. Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors. Pancreatol 2021; 21:240-245. View at Publisher View at Google Scholar View at Indexing
Ugras N, Hasdemir S, Yerci O, Ta?ar P, Dündar HZ, Macunluo?lu AC. Do morphologic characteristics play a role in nodal metastatic progression of well-differentiated pancreatic neuroendocrine tumors? Tumori 2021; 107:80-85. [PMID: 32705937]. View at Publisher View at Google Scholar View at Indexing
Croitoru A, Dinu I, Herlea V, Becheanu G, Grasu M, Lupescu I, et al. LARGE CELL METASTATIC PANCREATIC NEUROENDOCRINE CARCINOMA TREATED WITH SOMATOSTATIN ANALOGUES - CASE REPORT AND LITERATURE REVIEW. Acta Endocrinol (Buchar) 2019; 15:390-397. [PMID: 32010361]. View at Publisher View at Google Scholar View at Indexing
Prev 1 2 3 4 5 6 7 8 9 10 Next »

Awards Nomination

PMC/PubMed Indexed Articles

Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma
Screening of Pancreatic Cancer

Journal of the Pancreas Open Access

Important citations

Guerra F, Barucca V, Coletta D. Metastases or primary recurrence to the lung is related to improved survival of pancreatic cancer as compared to other sites of dissemination. Results of a systematic review with meta-analysis. Eur J Surg Oncol 2020; 46:1789-1794. [PMID: 32753117]

Sahni S, Moon EA, Howell VM, Mehta S, Pavlakis N, Chan D, et al. Tissue biomarker panel as a surrogate marker for squamous subtype of pancreatic cancer. Eur J Surg Oncol 2020; 46:1539-1542. [PMID: 32061458].

Hyde AJ, Nassabein R, AlShareef A, Armstrong D, Babak S, Berry S, et al. Eastern Canadian gastrointestinal cancer consensus conference 2018. Current Oncology 2019; 26:665-681. [PMID: 31708660].

Suzuki F, Fujiwara Y, Hamura R, Haruki K, Sakamoto T, Shiba H, et al. Combination of distance from superior mesenteric artery and serum CA19-9 as a novel prediction of local recurrence in patients with pancreatic cancer following resection. Anticancer Res 2019; 39:1469-78.

Furukawa K, Shiba H, Hamura R, Haruki K, Fujiwara Y, Usuba T, et al. Prognostic factors in patients with recurrent pancreatic cancer: A multicenter database analysis. Anticancer Res 2020; 40:293-298. [PMID: 31892579].

Tanaka M, Mihaljevic AL, Probst P, Heckler M, Klaiber U, Heger U, et al. Meta-analysis of recurrence pattern after resection for pancreatic cancer. Journal of British Surgery 2019; 106:1590-601. [PMID: 31454073].

Xelwa N, Candy GP, Devar J, Omoshoro-Jones J, Smith M, Nweke EE. Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance. Front Oncol. 2021; 11: 683788. [PMID: 34195085].

Frequency of Raised Serum CRP in Acute Pancreatitis- A CrossSectional Study at Lahore General Hospital. PJMHS 2018; 12:999-1001.

Kim DU, Bae GS, Kim MJ, Choi JW, Kim DG, Song HJ, Park SJ. Icariin attenuates the severity of cerulein?induced acute pancreatitis by inhibiting p38 activation in mice. Int J Mol Med 2019; 44:1563-73. [PMID: 31432106].

Dima A, Balaban DV, Jurcut C, Jinga M. Systemic lupus erythematosus-related acute pancreatitis. Lupus 2021; 30:5-14. [PMID: 33307986].

Chue BM, La Course BD. Can we cure stage IV triple-negative breast carcinoma? Another case report of long-term survival (7 years). Medicine (Baltimore) 2019; 98:e17251. [PMID: 31567994].

Chue BM, La Course BD. Case report of long-term survival with metastatic triple-negative breast carcinoma- Treatment possibilities for metastatic disease. Medicine (Baltimore). 2019; 98:e15302. [PMID: 31008982].

de Vries C, Konukiewitz B, Weichert W, Klöppel G, Aupperle-Lellbach H, Steiger K. Do Canine Pancreatic Neuroendocrine Neoplasms Resemble Human Pancreatic Neuroendocrine Tumours? A Comparative Morphological and Immunohistochemical Investigation. J Comp Pathol 2020; 181:73-85. [PMID: 33288156].

Segaran N, Devine C, Wang M, Ganeshan D. Current update on imaging for pancreatic neuroendocrine neoplasms. World J Clin Oncol 2021; 12:897-911. [PMID: 34733612].

Khanna L, Prasad SR, Sunnapwar A, Kondapaneni S, Dasyam A, Tammisetti VS, et al. Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification. Radiographics 2020; 40:1240-1262. [PMID: 32795239].

Oka N, Kasajima A, Konukiewitz B, Sakurada A, Okada Y, Kameya T. Classification and Prognostic Stratification of Bronchopulmonary Neuroendocrine Neoplasms. Neuroendocrinology 2020; 110:393-403. [PMID: 31422400].

The Molecular and Clinical Landscape of Pancreatic Neuroendocrine Tumors. Pancreas 2019; 48:9-21. [PMID: 30531241].

Wan Y, Hao H, Meng S, Li Z, Yu F, Chi M, et al. Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors. Pancreatol 2021; 21:240-245.

Ugras N, Hasdemir S, Yerci O, Ta?ar P, Dündar HZ, Macunluo?lu AC. Do morphologic characteristics play a role in nodal metastatic progression of well-differentiated pancreatic neuroendocrine tumors? Tumori 2021; 107:80-85. [PMID: 32705937].

Croitoru A, Dinu I, Herlea V, Becheanu G, Grasu M, Lupescu I, et al. LARGE CELL METASTATIC PANCREATIC NEUROENDOCRINE CARCINOMA TREATED WITH SOMATOSTATIN ANALOGUES - CASE REPORT AND LITERATURE REVIEW. Acta Endocrinol (Buchar) 2019; 15:390-397. [PMID: 32010361].

PMC/PubMed Indexed Articles

Google Scholar citation report

Citations : 39440

Abstracted/Indexed in

Useful Links

Share This Page

Open Access Journals